Results 81 to 90 of about 10,763 (250)

An international study on emerging arboviral infections and blood safety

Transfusion, EarlyView.
Abstract Background Emerging and re‐emerging arboviral infections are a risk to blood safety. We conducted an international survey on how blood establishments respond to current and future arbovirus threats. Study Design and Methods A questionnaire on arbovirus donor deferral strategies, pathogen reduction, and donation screening was distributed to ...
Piya Rajendra, Helen M. Faddy, Daniel Candotti, Carolina B. Bub, Jose M. Kutner, Steven J. Drews, Carmen L. Charlton, Sheila F. O'Brien, Wai‐Chiu Tsoi, Michel‐Andres Garcia‐Otalora, Claire Reynolds, Tuulia Palukka, Riikka Lehtisalo, Ruth Offergeld, Axel Seltsam, Marijke Weber‐Schehl, Nahid Chenarsabz, Naoko Goto, Sung‐Chan Park, So‐Yong Kwon, Ryanne Lieshout‐Krikke, Aneta Kopacz, Ewa Sulkowska, Oana‐Alexandra Șerban, Simona Ruta, Eugene Zhiburt, Maha Badawi, Josephine Mitchel, Ute Jentsch, Ángel Luis Pajares Herraiz, Ana Lafuente Guijosa, Gülşen Özkaya Şahin, Christoph Niederhauser, Marion C. Lanteri, Brian Custer, Galen Conti, Anthea Cheng, Shannah Secret, Peter Simmonds, Heli Harvala, on behalf of the Virology subgroup of the ISBT WP‐TTID   +40 more
wiley   +1 more source

Estimates and prevention of Crimean-Congo hemorrhagic fever risks for health-care workers

, 2007
Crimean-Congo hemorrhagic fever virus (CCHFV) is one of the most widespread pathogens causing viral hemorrhagic fever (VHF). A disease with the clinical and epidemiological features of Crimean-Congo hemorrhagic fever (CCHF) has been long known in Central

core   +1 more source

Crimean–Congo Hemorrhagic Fever Virus: Advances in Vaccine Development [PDF]

BioResearch Open Access, 2020
Crimean-Congo hemorrhagic fever (CCHF) is a severe human disease with mortality rates of up to 30%. The disease is widespread in Africa, Asia, the Middle East and Eastern Europe. The last few years have seen disease emergence in Spain for the first time and disease re-emergence in other regions of the world after periods of inactivity. Factors, such as
Tipih, Thomas, Burt, Felicity Jane
openaire   +2 more sources

The Results of Detecting Genetic Markers of Infectious Disease Pathogens Transmitted by Ixodidae Ticks in Certain Regions of the Republic of the Congo

Проблемы особо опасных инфекций
This study was conducted in order to identify genetic markers of pathogens (RNA, 16S rRNA or DNA) of natural-focal infectious diseases of bacterial, viral and rickettsial origin in suspensions of Ixodidae ticks collected in certain regions of the ...
E. V. Naidenova, K. S. Zakharov, A. P. Smolina, I. M. Shpak, G. Dzeret Indolo, F. Koukouikila-Koussounda, W. S. Mouellet, S. D. Katyshev, Ya. M. Krasnov, T. A. Polunina, N. V. Kotova, E. Okemba Ongagna, F. Kangoula-Dia-Kikoudi, P. I. Mayengue, F. R. Niama, V. V. Kutyrev   +15 more
doaj   +1 more source

A case of brucellosis mimicking Crimean-Congo hemorrhagic fever

Journal of Infection and Public Health, 2015
Summary: Brucellosis is a zoonotic disease caused by Brucella spp. that is transmitted to humans by the ingestion of unpasteurized milk and other dairy products from infected animals or through close contact with secretions.
Ozge Metin, Turkan A. Teke, Zeynep G. Gayretli Aydin, Ayse Kaman, Fatma N. Oz, Gulsum I. Bayhan, Gonul Tanir   +6 more
doaj   +1 more source

LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus

Cell Research
Crimean-Congo hemorrhagic fever virus (CCHFV) is the most widespread tick-born zoonotic bunyavirus that causes severe hemorrhagic fever and death in humans.
Zhi-Sheng Xu, Wen-Tian Du, Su-yun Wang, Moyu Wang, Yi-Ning Yang, Yuhua Li, Zhen-Qi Li, Lixin Zhao, Yan Yang, Wei-Wei Luo, Yan-Yi Wang   +10 more
semanticscholar   +1 more source

A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus

Antiviral Research, 2016
This article provides a definitive review of experimental studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus (CCHFV), the etiologic agent of Crimean-Congo hemorrhagic fever (CCHF)
J. Spengler, A. Estrada-Peña, A. Garrison, C. Schmaljohn, C. Spiropoulou, É. Bergeron, D. Bente   +6 more
semanticscholar   +1 more source

Clinical and pathologic features of Crimean-Congo hemorrhagic fever

, 2007
This chapter describes the story of the clinical process starting from the entrance of the virus to the human body to the death, if happens. Humans are the only known host of Crimean-Congo hemorrhagic fever virus (CCHFV) in which disease is manifested ...

core   +1 more source

Crimean‐Congo Haemorrhagic Fever Virus Exposure in Horses and Donkeys in Border Livestock Markets of Nigeria

Zoonoses and Public Health, EarlyView.
ABSTRACT Introduction Crimean‐Congo haemorrhagic fever virus (CCHFV) is a tick‐borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade.
David O. Ehizibolo, Olumuyiwa Oyekan, Nicodemus Mkpuma, Habibu Haliru, Ibrahim Garba, Isa Z. Turaki, Samdi Kennedy, Joshua M. Shallangwa, Caleb S. Kilyobas, Abdullahi Mohammed, Musa A. Muhammad, Mansur Abubakar, Maryam Muhammad, Corrie Brown, Bonto Faburay   +14 more
wiley   +1 more source

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1650-1661, June 2026.
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland, Richard FitzGerald, Elizabeth Challenger, Laura Dickinson, Laura J. Else, Lauren Walker, Colin Hale, Victoria Shaw, Callum Kelly, Rebecca Lyon, Jennifer Gibney, Karim Dhamani, Margaret Irwin, Yvanne Enever, Michelle Tetlow, William Wood, Helen Reynolds, Justin Chiong, Orod Osanlou, Henry Pertinez, Katie Bullock, William Greenhalf, Andrew Owen, David G. Lalloo, Michael Jacobs, Julian A. Hiscox, Thomas Jaki, Pavel Mozgunov, Geoffrey Saunders, Gareth Griffiths, Saye H. Khoo, Thomas E. Fletcher, on behalf of the AGILE CST‐6 Study Group, Shazaad Ahmad, Christopher J. Edwards, Lesley Dry, Georgie McKenzie, Aleksandra Ros, Michael Stackpoole, Laura Bradley, Karen Jennings‐Wilding, Nicholas Paton, Fred Hayden, Janet Darbyshire, Amy Lucas, Ulrika Lorch, Andrew Freedman, Richard Knight, Steven Julious   +48 more
wiley   +1 more source